Gene Salkind

Gene Z.
Salkind is currently Chairman at Mobiquity Technologies, Inc. since 2019.
Independent Director at Upexi, Inc. since 2021.
Independent Director at Avenir Wellness Solutions, Inc. since 2018.
Independent Director at Coeptis Therapeutics Holdings, Inc. since 2022.
Director at Grove Holdings, Inc. since 2011.
Director at CURE Pharmaceutical Corp.
since 2018.
Chief of Neurosurgery at Holy Redeemer Health System since 2001.
Trustee at Calico Capital Management LLC.
Trustee-Emeritus at Temple University School of Medicine.
Professor at Lewis Katz School of Medicine.
President at Bruno & Salkind Mds since 1985.
Formerly Director at DermTech Operations, Inc. from 2014 to 2020.
Director at DermTech, Inc. from 2014 to 2020.
Professor at the University of Pennsylvania.
Professor at Allegheny Health, Education & Research Foundation.
Chief of Neurosurgery at Jeanes Hospital from 1990 to 2000.
Chief of Neurosurgery at Albert Einstein Medical Center from 1997 to 2002.
Chief Resident at The Hospital of The University of Pennsylvania.
Education includes undergraduate degree from the University of Pennsylvania in 1974 and doctorate from Lewis Katz School of Medicine in 1979.